It’s In The Mail: Aetna Agrees To $17M Payout In HIV Privacy Breach
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
Health Industry
2,281 - 2,300 of 3,879 Results
-
-
Podcast: What The Health? Our First Live Show: What The Health Will Happen In 2018?
In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.
-
Home Care Agencies Often Wrongly Deny Medicare Help To The Chronically Ill
Agencies sometimes turn away Medicare beneficiaries with chronic health problems by incorrectly claiming Medicare won't pay for their services, say patient advocates.
By Susan Jaffe -
Inside The Global Race To Deliver A Vital Radioactive Isotope Used To Detect Cancer
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
By Sarah Varney -
When You Need A Breast Screening, Should You Get A 3-D Mammogram?
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
-
J.P. Morgan Health Conference All About The Deals Amid Uncertainty For Millions
The lofty ideas floated and billion-dollar deals sealed at J.P. Morgan’s elite annual conference stand in stark contrast to the uncertainty that clouds health care outside its confines.
-
Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?
In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.
-
Listen: How A ‘Hippie Clinic’ In San Francisco Inspired A Medical Philosophy
The Haight Ashbury Free Clinic still serves people living on the fringes in San Francisco. This radio story recounts its 51-year history.
-
Despite Prod By ACA, Tax-Exempt Hospitals Slow To Expand Community Benefits
The Affordable Care Act mandated that hospitals exempt from taxes work to provide health benefits to the community. But a study finds that has been slow to get off the ground.
-
Grassley Calls For ‘Corrective Action’ On Abuses In Herpes Vaccine Research
The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.
-
Half Of Hospitals In Conn., Del. Hit By Medicare’s Safety Penalties
Seven states saw a third or more of their hospitals punished under the federal heath law’s campaign against hospital-acquired conditions.
By Jordan Rau -
Readers Have Bones To Pick, From Health System Flaws To Covering Pot Beat
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Pharmacists Slow To Dispense Lifesaving Overdose Drug
Laws in California and most other states allow pharmacists to provide naloxone to patients or their friends without a doctor’s prescription. But many don’t do so, citing lack of demand and awareness among patients, their own fears of insufficient compensation and the challenges of treating opioid users.
By Anna Gorman -
Terrifying Brush With Death Drives Doctor To Fight For Patients
Dr. Rana Awdish was completing a fellowship in critical care when she became critically ill herself. Now, she helps other doctors understand the patient’s perspective.
-
Care Suffers As More Nursing Homes Feed Money Into Corporate Webs
Increasingly, owners of nursing homes outsource services to companies in which they also have financial interest or control. That allows the nursing homes to claim to be in the red while owners reap hidden profits.
By Jordan Rau -
Trump Administration Relaxes Financial Penalties Against Nursing Homes
Medicare is discouraging regional offices from levying fines for “one-time mistakes” or from using daily fines that seek to put pressure on nursing homes to make changes.
By Jordan Rau -
Sickle Cell Patients, Families And Doctors Face A ‘Fight For Everything’
Premature death, a dearth of treatments, mistreatment in emergency rooms and a woeful lack of funding are just a few of the problems confronting people with sickle cell disease.
By Jenny Gold -
FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs
The FDA’s Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.
-
Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
-
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.